Related Experiment Video
Updated: Apr 11, 2026

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
SUMO pathway components as possible cancer biomarkers
Domenico Mattoscio1, Susanna Chiocca1
11Department of Experimental Oncology, European Institute of Oncology@ IFOM-IEO Campus, Via Adamello 16, 20139 Milan, Italy.
Small Ubiquitin-related MOdifier (SUMO)ylation is a critical cellular process. SUMO pathway alterations are linked to human cancers, suggesting potential as cancer biomarkers.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- SUMOylation is a crucial post-translational modification regulating cellular functions.
- The Small Ubiquitin-related MOdifier (SUMO) pathway plays a fundamental role in various biological processes.
- Dysregulation of SUMOylation is implicated in cellular dysfunction and disease pathology.
Purpose of the Study:
- To explore the link between the SUMO pathway and human malignancies.
- To investigate the role of SUMOylation in tumorigenesis.
- To discuss the potential of SUMO pathway components as cancer biomarkers.
Main Methods:
- Review of recent findings on SUMOylation in cancer.
- Analysis of the impact of SUMO pathway component alterations on cellular properties.
- Exploration of SUMO enzymes' role in predicting cancer behavior.
Main Results:
- Alterations in SUMO pathway components can subvert cellular properties, influencing proliferation, apoptosis resistance, and metastasis.
- A clear association between the SUMO pathway and human malignancies has been identified.
- SUMO enzymes show potential in predicting cancer progression and behavior.
Conclusions:
- The SUMO pathway is significantly involved in human tumorigenesis.
- SUMOylation is a key regulator of proteins implicated in carcinogenic pathways.
- Aberrations in SUMO pathway components may serve as valuable tumor biomarkers for cancer diagnosis and prognosis.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes

